Dillon & Associates Inc Regeneron Pharmaceuticals, Inc. Transaction History

Dillon & Associates Inc

$711 Million
Q3 2024

A detailed history of Dillon & Associates Inc transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Dillon & Associates Inc holds 13,525 shares of REGN stock, worth $9.67 Million. This represents 2.0% of its overall portfolio holdings.

Number of Shares

13,525

Previous 12,647 6.94%

Holding current value

$9.67 Million

Previous $13.3 Million 6.94%

% of portfolio

2.0%

Previous 1.93%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$1024.09 - $1201.76 $899,151 - $1.06 Million	878 Added 6.94%	13,525 $14.2 Million
Q2 2024 Aug 06, 2024	BUY	$883.2 - $1071.19 $246,412 - $298,862	279 Added 2.26%	12,647 $13.3 Million
Q1 2024 Apr 30, 2024	BUY	$902.69 - $993.35 $517,241 - $569,189	573 Added 4.86%	12,368 $11.9 Million
Q4 2023 Feb 08, 2024	SELL	$775.18 - $881.7 $268,212 - $305,068	-346 Reduced 2.85%	11,795 $10.4 Million
Q3 2023 Nov 13, 2023	BUY	$692.45 - $844.37 $261,746 - $319,171	378 Added 3.21%	12,141 $9.99 Million
Q2 2023 Aug 08, 2023	BUY	$700.03 - $830.35 $622,326 - $738,181	889 Added 8.18%	11,763 $8.46 Million
Q1 2023 May 02, 2023	BUY	$680.49 - $826.97 $1.13 Million - $1.37 Million	1,656 Added 17.96%	10,874 $8.94 Million
Q1 2023 May 01, 2023	SELL	$680.49 - $826.97 $889,400 - $1.08 Million	-1,307 Reduced 12.42%	9,218 $7.57 Million
Q4 2022 Feb 06, 2023	SELL	$705.89 - $766.39 $705 - $766	-1 Reduced 0.01%	10,525 $7.59 Million
Q3 2022 Nov 08, 2022	BUY	$573.97 - $724.32 $251,972 - $317,976	439 Added 4.35%	10,526 $7.25 Million
Q2 2022 Jul 26, 2022	BUY	$548.35 - $738.84 $194,115 - $261,549	354 Added 3.64%	10,087 $5.96 Million
Q1 2022 May 06, 2022	BUY	$595.12 - $698.43 $306,486 - $359,691	515 Added 5.59%	9,733 $6.79 Million
Q4 2021 Feb 14, 2022	BUY	$543.48 - $670.97 $740,219 - $913,861	1,362 Added 17.34%	9,218 $5.83 Million
Q3 2021 Oct 28, 2021	BUY	$574.03 - $680.96 $857,026 - $1.02 Million	1,493 Added 23.46%	7,856 $4.75 Million
Q2 2021 Aug 02, 2021	BUY	$472.8 - $558.54 $1.34 Million - $1.58 Million	2,826 Added 79.9%	6,363 $3.56 Million
Q1 2021 May 10, 2021	BUY	$446.73 - $548.2 $1.58 Million - $1.94 Million	3,537 New	3,537 $1.67 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $76.6B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dillon & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Dillon & Associates Inc with notifications on news.

Account

Dillon & Associates Inc Regeneron Pharmaceuticals, Inc. Transaction History